Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation

Thrombosis and Haemostasis

Volumn 113, Issue 2, 2015, Pages 329-337

  Ahmad, Shakil ^a   Hewett, Peter W ^b   Fujisawa, Takeshi ^b   Sissaoui, Samir ^b   Cai, Meng ^a   Gueron, Geraldine ^c   Al Ani, Bahjat ^b   Cudmore, Melissa ^b   Faraz Ahmed, S ^d   Wong, Michael K K ^e   Wegiel, Barbara ^a,f   Otterbein, Leo E ^a,f   Vítek, Libor ^g   Ramma, Wenda ^f   Wang, Keqing ^a   Ahmed, Asif ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Angiogenesis; Carbon monoxide; Endothelial cells; Vascular endothelial growth factor; Vascular endothelial growth factor receptor 2

Indexed keywords

ACTIN; CARBON MONOXIDE; CYTOCHROME C OXIDASE; FIBROBLAST GROWTH FACTOR 2; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; TYROSINE; VASCULOTROPIN RECEPTOR 2; COLLAGEN; DRUG COMBINATION; LAMININ; MATRIGEL; ORGANOMETALLIC COMPOUND; PROTEOGLYCAN; RECOMBINANT PROTEIN; TRICARBONYLDICHLORORUTHENIUM (II) DIMER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN;

ANGIOGENESIS; ANGIOGENESIS ASSAY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHOSPHORYLATION;

ANIMALS; CARBON MONOXIDE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; LAMININ; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PHOSPHORYLATION; PROTEOGLYCANS; RECOMBINANT PROTEINS; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84922477670     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-01-0002     Document Type: Article

References (49)

1. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularisation: NO for endothelial progenitor cells. Trends Mol Med 2004; 10: 143-145.
2. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
3. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischaemia. J Clin Invest 1998; 101: 2567-2578.
4. Ahmad S, Hewett PW, Wang P, et al. Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res 2006; 99: 715-722.
5. Dulak J, Deshane J, Jozkowicz A, et al. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 2008; 117: 231-241.
6. Christodoulides N, Durante W, Kroll MH, et al. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 1995; 91: 2306-2309.
7. Kaide JI, Zhang F, Wei Y, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2001; 107: 1163-1171.
8. Mansouri A, Perry CA. Alteration of platelet aggregation by cigarette smoke and carbon monoxide. Thromb Haemost 1982; 48: 286-288.
9. Yet SF, Layne MD, Liu X, et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003; 17: 1759-1761.
10. Moulton KS, Vakili K, Zurakowski D, et al. Inhibition of plaque neovascularisation reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003; 100: 4736-4741.
11. Celletti FL, Hilfiker PR, Ghafouri P, et al. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. J Am Coll Cardiol 2001; 37: 2126-2130.
12. Tenhunen R, Marver HS, Schmid R. Microsomal heme oxygenase. Characterisation of the enzyme. J Biol Chem 1969; 244: 6388-6394.
13. Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103: 1047-1054.
14. Bussolati B, Ahmed A, Pemberton H, et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004; 103: 761-766.
15. Abraham NG, Scapagnini G, Kappas A. Human heme oxygenase: cell cycle-dependent expression and DNA microarray identification of multiple gene responses after transduction of endothelial cells. J Cell Biochem 2003; 90: 1098-1111.
16. Deramaudt BM, Braunstein S, Remy P, et al. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem 1998; 68: 121-127.
17. Deshane J, Chen S, Caballero S, et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 2007; 204: 605-618.
18. Li Volti G, Sacerdoti D, Sangras B, et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 2005; 7: 704-710.
19. Sato K, Balla J, Otterbein L, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001; 166: 4185-4194.
20. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-428.
21. Wegiel B, Gallo D, Csizmadia E, et al. Carbon monoxide expedites metabolic exhaustion to inhibit tumour growth. Cancer Res 2013; 73: 7009-7021.
22. Gueron G, De Siervi A, Ferrando M, et al. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res 2009; 7: 1745-1755.
23. Vitek L, Gbelcova H, Muchova L, et al. Antiproliferative effects of carbon monoxide on pancreatic cancer. Digest Liver Dis 2014; 46: 369-375.
24. Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nature Rev Drug Discov 2010; 9: 728-743.
25. Motterlini R, Clark JE, Foresti R, et al. Carbon monoxide-releasing molecules: characterisation of biochemical and vascular activities. Circ Res 2002; 90: E17-24.
26. Bussolati B, Dunk C, Grohman M, et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993-1008.
27. Sawle P, Foresti R, Mann BE, et al. Carbon monoxide-releasing molecules (CORMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264. 7 murine macrophages. Br J Pharmacol 2005; 145: 800-810.
28. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007; 115: 1789-1797.
29. Ahmad S, Cudmore MJ, Wang K, et al. Angiopoietin-1 induces migration of monocytes in a tie-2 and integrin-independent manner. Hypertension 2010; 56: 477-483.
30. Nehls V, Drenckhahn D. A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 1995; 50: 311-322.
31. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
32. Ross JF, Liu X, Dynlacht BD. Mechanism of transcriptional repression of E2F by the retinoblastoma tumour suppressor protein. Mol Cell 1999; 3: 195-205.
33. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine & growth factor reviews 2005; 16: 139-149.
34. Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371.
35. Kureishi Y, Luo Z, Shiojima I, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004-1010.
36. Ryter SW, Alam J, Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650.
37. Rose CS, Jones RA, Jenkins LJ, Jr., et al. The acute hyperbaric toxicity of carbon monoxide. Toxicol Appl Pharmacol 1970; 17: 752-760.
38. Chekhonin VP, Shein SA, Korchagina AA, et al. VEGF in tumour progression and targeted therapy. Current cancer drug targets 2013; 13: 423-443.
39. Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-532.
40. Togane Y, Morita T, Suematsu M, et al. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol 2000; 278: H623-632.
41. Fischer C, Jonckx B, Mazzone M, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumours without affecting healthy vessels. Cell 2007; 131: 463-475.
42. Matsumoto T, Bohman S, Dixelius J, et al. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumour angiogenesis. EMBO J 2005; 24: 2342-2353.
43. Sakurai Y, Ohgimoto K, Kataoka Y, et al. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 2005; 102: 1076-1081.
44. Takahashi T, Yamaguchi S, Chida K, et al. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001; 20: 2768-2778.
45. Batzlsperger CA, Achatz S, Spreng J, et al. Evidence for a possible inhibitory interaction between the HO-1/CO-and Akt/NO-pathways in human endothelial cells. Cardiovasc Drugs Ther 2007; 21: 347-355.
46. Dulak J, Jozkowicz A, Foresti R, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4: 229-240.
47. Nanobashvili J, Jozkowicz A, Neumayer C, et al. Comparison of Angiogenic Potential of Human Microvascular Endothelial Cells and Human Umbilical Vein Endothelial Cells. Eur Surg 2003; 35: 214-219.
48. Page C, Rose M, Yacoub M, et al. Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992; 141: 673-683.
49. Huk I. Comparison of angiogenic potential of human microvascular endothelial cells and human umbilical vein endothelial cells. Eur Surg Res 2003; 35: 214-218.